About the role
<div class="content-intro"><h2>Your work will change lives. Including your own.&nbsp;</h2> <p><iframe style="width: 655px; height: 367px;" src="https://www.youtube.com/embed/NzerLX6koWI?si=KaDRt0AYxcwmtZus" width="655" height="367"></iframe></p></div><h4><strong>The Impact You’ll Make</strong></h4> <p>At Recursion, we are decoding biology to radically improve lives. As Vice President, Medical Affairs, you will help shape how Recursion translates breakthrough science, clinical data, real-world evidence, and AI-enabled insights into meaningful impact for patients, clinicians, investigators, and health systems.</p> <p>You will build and lead the Medical Affairs strategy across Recursion’s advancing clinical portfolio, with an initial focus on programs in areas of significant unmet need, including oncology, rare disease, immunology, and other priority therapeutic areas. This is a high-impact, cross-functional leadership role for a strategic medical affairs leader who can operate from early development through launch readiness, bring the external medical voice into portfolio decisions, and establish scalable capabilities for scientific engagement, evidence generation, medical communications, and medical excellence.</p> <h4><strong>In this role, you will:</strong></h4> <ul> <li>Develop and lead integrated Medical Affairs strategies for priority assets, including scientific narrative, evidence gaps, stakeholder engagement, publication strategy, medical education, advisory boards, field medical planning, and launch readiness.</li> <li>Provide Medical Affairs support on cross-functional asset teams, partnering with Clinical Development, Regulatory Affairs, Development Sciences, HEOR/RWE, Biostatistics, Clinical Operations, Portfolio Strategy, Patient Advocacy, Communications, Legal/Compliance, and Business Development, where appropriate.</li> <li>Build evidence-generation plans that support asset differentiation, patient benefit, clinical adoption, and value demonstration, including real-world evidence, HEOR, epidemiology, natural history, burden of disease, treatment patterns, and outcomes-focused studies.</li> <li>Translate external insights from healthcare professionals, investigators, patient communities, payers, health systems, and scientific leaders into actionable recommendations for development strategy, trial design, endpoints, education needs, and evidence priorities.</li> <li>Lead scientific engagement strategy with key opinion leaders, digital opinion leaders, investigators, cooperative groups, patient advocacy organizations, professional societies, and other external stakeholders through compliant, high-quality scientific exchange.</li> <li>Lead congress and conference strategy for priority programs,